Treatment hyperphosphatemia in hemodialysis patient
Phase 2
- Conditions
- hyperphosphatemia in hemodialysis.Extracorporeal dialysis
- Registration Number
- IRCT201011295275N1
- Lead Sponsor
- Vice chancellor for research, Tabriz University of Medical Sciences and Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
include criteria:
1)age>15
2)phosphore>5.5
3)more than 6 month to beginning in hemodialysis
exclude criteria:
1)patient refuse
2)drug adverse
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hyperphosphatemia. Timepoint: once two weeks. Method of measurement: serum phosphor checked.
- Secondary Outcome Measures
Name Time Method HDL. Timepoint: Once two weeks. Method of measurement: HDL in serum checked.;PTH. Timepoint: Once two weeks. Method of measurement: PTH in serum checked.